Processing of pro-brain natriuretic peptide is suppressed by O-glycosylation in the region close to the cleavage site. - Wikidata - awgldk - TriplyDB

Processing of pro-brain natriuretic peptide is suppressed by O-glycosylation in the region close to the cleavage site.

Processing of pro-brain natriuretic peptide is suppressed by O-glycosylation in the region close to the cleavage site.

http://www.wikidata.org/entity/Q34929505

about

Natriuretic Peptides in the Regulation of Cardiovascular Physiology and Metabolic Events Fibrous dysplasia and fibroblast growth factor-23 regulation INTERACTING DISCIPLINES: Cardiac natriuretic peptides and obesity: perspectives from an endocrinologist and a cardiologist Depletion of proBNP1-108 in patients with heart failure prevents cross-reactivity with natriuretic peptides Ghrelin-like peptide with fatty acid modification and O-glycosylation in the red stingray, Dasyatis akajei.O-glycosylation modulates proprotein convertase activation of angiopoietin-like protein 3: possible role of polypeptide GalNAc-transferase-2 in regulation of concentrations of plasma lipids Secretion of prohormone of B-type natriuretic peptide, proBNP1-108, is increased in heart failure.An antibody reactive to the Gly63-Lys68 epitope of NT-proBNP exhibits O-glycosylation-independent binding.BNP molecular forms and processing by the cardiac serine protease corin.Corin in natriuretic peptide processing and hypertension Measurement of nonsulfated cholecystokinins.Relationship between N-terminal pro-brain natriuretic peptide, obesity and the risk of heart failure in middle-aged German adults.Site-specific characterization of threonine, serine, and tyrosine glycosylations of amyloid precursor protein/amyloid beta-peptides in human cerebrospinal fluid Glycosylation and processing of pro-B-type natriuretic peptide in cardiomyocytes.Corin in clinical laboratory diagnostics Aberrant Glycosylation in the Left Ventricle and Plasma of Rats with Cardiac Hypertrophy and Heart Failure.Mucin-type O-glycosylation is controlled by short- and long-range glycopeptide substrate recognition that varies among members of the polypeptide GalNAc transferase family.Posttranslational processing of human and mouse urocortin 2: characterization and bioactivity of gene products Secretion of glycosylated pro-B-type natriuretic peptide from normal cardiomyocytes.O-Glycosylation of a Secretory Granule Membrane Enzyme Is Essential for Its Endocytic Trafficking Analytical Issues with Natriuretic Peptides - has this been Overly Simplified?Cardiac natriuretic peptides: from basic discovery to clinical practice.Measurement of the pro-hormone of brain type natriuretic peptide (proBNP): methodological considerations and pathophysiological relevance.MS-based approaches to unravel the molecular complexity of proprotein-derived biomarkers and support their quantification: the examples of B-type natriuretic peptide and apelin peptides.State of the art of immunoassay methods for B-type natriuretic peptides: An update.BNP in children with congenital cardiac disease: is there now sufficient evidence for its routine use?Post-translational modifications enhance NT-proBNP and BNP production in acute decompensated heart failure.Liquid chromatography-tandem mass spectrometry-based fragmentation analysis of glycopeptides.Natriuretic peptides as biomarkers of cardiac endocrine function in heart failure: new challenges and perspectives.Brain natriuretic peptide and right heart dysfunction after heart transplantation.Three molecular forms of atrial natriuretic peptides: quantitative analysis and biological characterization.A systematic study of site-specific GalNAc-type O-glycosylation modulating proprotein convertase processing.Mechanism of FGF23 processing in fibrous dysplasia.A sensor of protein O-glycosylation based on sequential processing in the Golgi apparatus.Effect of sialylated O-glycans in pro-brain natriuretic peptide stability.Will sacubitril-valsartan diminish the clinical utility of B-type natriuretic peptide testing in acute cardiac care?MiR30-GALNT1/2 Axis-Mediated Glycosylation Contributes to the Increased Secretion of Inactive Human Prohormone for Brain Natriuretic Peptide (proBNP) From Failing Hearts.Enhancement of C2C12 myoblast proliferation and differentiation by GASP-2, a myostatin inhibitor Old tool - new application: NT-proBNP in fetal medicine.Pro-B-type natriuretic peptide is cleaved intracellularly: impact of distance between O-glycosylation and cleavage sites.

P2860

Q26778333-CEA9D39A-4FEF-4DC9-86AE-2E85BBAC7467 Q27010789-EA38B241-8ABE-432C-A80D-8A0BCD6A024B Q28083473-FEC868D0-5AB4-4444-AFD1-8CA26C4FCA38 Q28533555-22B13BFA-6078-4E09-AB55-787BB030F468 Q33517970-D94380DF-A614-46AD-BCCE-0F009A17E09D Q33691116-398515B1-7994-4BC8-A377-EFA84A7F30A9 Q33994980-E92BA31A-BC57-4F91-A71F-5C9C3651330A Q34284107-75642AE6-CF99-4535-96FC-B17A096A8D21 Q34369603-60D9A10B-8826-4461-885D-2D7A4FB33FA2 Q34396853-215B1004-351A-428B-AE21-EBC72BB0B257 Q34415302-E79D7AAD-3DFB-48FA-A5DB-059A1C85D0D6 Q34571982-FEA2A0D8-EABE-429F-B90E-7619CD7F9B55 Q35123119-B42D81CB-C5E4-4757-BB41-1581CF6FE2B5 Q35154172-AD02CC71-9377-4C3E-A6DA-67C91D7802E3 Q35634038-06977622-0501-4A10-BB15-81A5D933BBF4 Q36046973-D654B131-7FD3-422A-BCA0-2F0086D2A46D Q36617733-C5EF66D4-3E18-44F7-B691-403FE15454E4 Q36699526-54EE6235-DF27-4FE4-AB15-34D1E13D4CB1 Q36790719-644F095E-971A-449A-8020-871049AA1EEC Q36850110-FA7048F1-8DF9-43A5-A61E-D1197B1E5DA8 Q37229313-7E72064E-4D2B-43FF-B241-AC35055A3CC8 Q37740228-68576EE5-A6B8-432E-9F58-2522C8AC9C79 Q37922195-21D77F5E-60FF-49C1-BFAA-C6F45C6A209B Q38065253-8BDD69AD-2A38-4187-894D-CD70F4BDA74D Q38303192-FB4F8427-1C54-495C-8784-F8412F5BF9D1 Q38324210-2F1B18B9-1920-455B-BE77-B813DBDCE625 Q38424871-DFC714C2-47A7-4706-A006-E78B09362A39 Q38701314-5CFC2778-0B6A-4251-A469-60B18F5515C1 Q38837698-C32574BF-C7DB-4DB6-BF14-EDFB21F65F89 Q38897414-F9C78107-5189-4227-90D5-072FD8429D4E Q39102349-BAD733C1-D0CF-456A-A4C3-FFEE4EBC719D Q39244694-71A40A22-4E73-4BF3-9EA7-66C4C94B9856 Q39411802-C6AC95FE-747B-4FAC-8976-D71EA91BAC24 Q39540176-6149949B-B4D7-4E0A-B392-6D674713773E Q39721683-F95A495D-A71E-43D2-82FC-35B3472E9CA4 Q40116429-9E33E687-BBDD-42FD-BD00-F0504543927F Q41102306-8BA45F8E-8C8A-4AAF-99E1-21453B26C81F Q41683166-15BE2776-9B2B-472C-9D0E-7B926C6E181A Q43968441-E6E6C8E6-3756-460D-9384-446FDF636BCE Q46706147-127F3D57-29F8-46A3-8E49-C25BFB7298C7

P2860

Processing of pro-brain natriuretic peptide is suppressed by O-glycosylation in the region close to the cleavage site.

http://www.wikidata.org/entity/Q34929505

description

2009 nî lūn-bûn

@nan

2009 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Processing of pro-brain natriu ...... on close to the cleavage site.

@ast

Processing of pro-brain natriu ...... on close to the cleavage site.

@en

Processing of pro-brain natriu ...... on close to the cleavage site.

@nl

type

label

Processing of pro-brain natriu ...... on close to the cleavage site.

@ast

Processing of pro-brain natriu ...... on close to the cleavage site.

@en

Processing of pro-brain natriu ...... on close to the cleavage site.

@nl

prefLabel

Processing of pro-brain natriu ...... on close to the cleavage site.

@ast

Processing of pro-brain natriu ...... on close to the cleavage site.

@en

Processing of pro-brain natriu ...... on close to the cleavage site.

@nl

P1433

Q34929505-AEDF10BC-8307-4FA6-8085-69CEA4A5A847

P1476

Q34929505-E81ABA19-EC79-4742-929E-D98EB138C1C2

P2093

Q34929505-03E74A93-6F48-45C4-95F5-3D69A9366CA8

Q34929505-2AAC5CB9-24E3-430B-B68A-2753A0D1F5C1

Q34929505-4410DD77-5D55-4189-BD5E-D3E92012E30A

Q34929505-4AB1E206-B6B0-417F-A5A5-98825DE0B927

Q34929505-57C2A00D-B461-4862-B6E0-2F9442C45E06

Q34929505-5FBC3D47-4E8A-4038-B6C1-386F8BD4F599

Q34929505-6CAAC738-968D-40BC-B7A0-D2FF268D7FBE

Q34929505-7D1DB658-8889-4ACA-BB9F-8897BF85868A

Q34929505-B04F6918-B3E4-41B5-AB7E-D1FA31371E14

Q34929505-D4113E15-B32D-4BC3-8CF0-43D0790A64F9

P304

Q34929505-5B88D96E-EC51-48C3-AD81-B489E471EA78

P31

Q34929505-8204C38D-1D80-4EFC-8D0B-B34E1A92AC2D

P356

Q34929505-17FDFD08-334B-4B19-9684-345D918E1066

P407

Q34929505-4192D491-22DE-4280-BDD7-D0EE9DB602AB

P433

Q34929505-6E837DE4-C252-4A0F-A02B-CBFEE1B9B99B

P478

Q34929505-6A36EF56-889A-4A63-B4F1-177ADF5D201B

P577

Q34929505-6C97680C-3644-4085-A9CA-A1AC10EFF03D

P698

Q34929505-68866DD1-5E27-4984-8D53-64CCE64F9332

P921

Q34929505-1E8ACDA7-8F91-4A8A-B153-26B2832FD7B3

Q34929505-5AA9797F-A557-4FEB-B5B8-6890B1076BA4

P356

CLINCHEM.2008.113373

P1433

Clinical Chemistry

P1476

Processing of pro-brain natriu ...... on close to the cleavage site.

@en

P2093

Alexander B Postnikov

http://www.w3.org/2001/XMLSchema#string

Alexander G Semenov

http://www.w3.org/2001/XMLSchema#string

Alexey G Katrukha

http://www.w3.org/2001/XMLSchema#string

Daria V Serebryanaya

http://www.w3.org/2001/XMLSchema#string

Ekaterina V Koshkina

http://www.w3.org/2001/XMLSchema#string

Karina R Seferian

http://www.w3.org/2001/XMLSchema#string

Marina N Bloshchitsyna

http://www.w3.org/2001/XMLSchema#string

Mihail I Krasnoselsky

http://www.w3.org/2001/XMLSchema#string

Natalia N Tamm

http://www.w3.org/2001/XMLSchema#string

Natalia S Karpova

http://www.w3.org/2001/XMLSchema#string

P304

489-498

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1373/CLINCHEM.2008.113373

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

55

http://www.w3.org/2001/XMLSchema#string

P577

2009-01-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19168558

http://www.w3.org/2001/XMLSchema#string

P921

brain natriuretic peptide